GLP-1 Coverage Ending? What to Do Next for Weight Loss

If your plan has just told you it'll stop paying for Wegovy or Zepbound, you're in a big and growing group. In its 2026 survey, the Business Group on Health found that 14% of large employers had already dropped GLP-1 coverage for weight loss or planned to drop it by 2027. On the public side, KFF counted 13 state Medicaid programs still covering these drugs for obesity in January 2026, down from 16 a few months earlier. The letter tends to arrive with a cutoff date and very little else.

What follows is the order most people actually work through it in. It starts with whether any route to coverage is left and what the drug costs if you pay for it yourself. After that comes the harder part: what stopping does to your weight, and whether weight-loss surgery deserves a place in the conversation.

What can you do when your GLP-1 coverage ends?

Start by confirming exactly what's ending and whether any route to coverage remains, then price the drug yourself. If neither works, plan a supervised stop with your doctor, and ask whether you meet the criteria for weight-loss surgery. Most people end up combining two of these rather than picking one.

A GLP-1 receptor agonist is a medicine that mimics glucagon-like peptide-1, a hormone your gut releases after eating, which slows how fast your stomach empties and turns down appetite. Semaglutide (sold as Wegovy for weight and Ozempic for type 2 diabetes) and tirzepatide (Zepbound and Mounjaro, which also acts on a second gut hormone) are the drugs most plans are pulling back on.

The wording of your plan's notice matters more than people expect. A lot of employers are ending coverage when the drug is prescribed for weight while keeping it for type 2 diabetes, so if you've been diagnosed with diabetes, ask your doctor whether your prescription was written under that diagnosis. And where coverage survives, it's rarely open-ended. KFF notes that state Medicaid programs that still cover GLP-1s for obesity typically put them behind prior authorization.

Prior authorization is a rule that your doctor has to get the plan's approval before it'll pay for a specific drug, usually by documenting that you meet set criteria such as a minimum BMI or a weight-related condition. If you've been denied, your denial letter should explain how to appeal, and it's worth asking your doctor whether your records support one.

If you're on Medicare, check the GLP-1 Bridge first

Medicare has gone the other way this year. Under the Medicare GLP-1 Bridge, eligible Part D enrollees can fill Wegovy, Foundayo or the Zepbound KwikPen for a flat $50 a month from July 1, 2026, and CMS has extended the program through December 31, 2027. You qualify with a BMI of 35 or more, or with a BMI of 30 or 27 alongside certain conditions, such as uncontrolled high blood pressure at 30 and prediabetes or a previous heart attack at 27. KFF estimated in June 2026 that about 3.8 million Part D enrollees met the criteria.

There are catches. The $50 doesn't count toward your Part D deductible or out-of-pocket cap, and Extra Help can't be used to lower it. Single-dose Zepbound pens and vials aren't covered at all. Nobody has said what replaces the Bridge after 2027 either, because CMS has put the Part D side of its longer-term BALANCE model on hold.

How much do Wegovy and Zepbound cost without insurance?

Self-pay prices fell sharply in late 2025. Novo Nordisk sells standard Wegovy pen doses for $349 a month through NovoCare, as Fierce Pharma reported in November 2025. Since December 2025, Eli Lilly has sold Zepbound single-dose vials through LillyDirect for $299 a month at the starting dose, rising to $449 at the higher doses. Over a year, that's roughly $3,600 to $5,400 for the drug alone.

Two things can bring that number down. IRS Publication 502 counts prescribed drugs as medical expenses, and it counts weight-loss treatment when a doctor has diagnosed a disease such as obesity, which is why many people can pay with pre-tax money. Our guide to using an HSA or FSA for treatment abroad covers the receipts you'll want to keep. Manufacturer prices also come with refill rules, so check that the price you're quoted is the one you'll pay at month four.

What doesn't bring it down without trouble is buying from an unknown seller. The FDA has warned companies selling unapproved semaglutide and tirzepatide labeled "for research purposes" or "not for human consumption", and in April 2025 it warned consumers about counterfeit Ozempic found in the US supply chain. If you're thinking about filling a prescription in another country, read our guide to GLP-1 drugs bought abroad before you go.

Will you regain the weight if you stop?

Most people regain a large share of it. In the STEP 1 trial extension, people who'd lost an average of 17.3% of their body weight over 68 weeks on semaglutide regained about two-thirds of that loss in the year after stopping, and their blood pressure and blood sugar improvements drifted back toward where they started.

That's from Wilding and colleagues, writing in Diabetes, Obesity and Metabolism in 2022. By week 120, the semaglutide group sat 5.6% below its starting weight on average, against 0.1% for the placebo group. The authors' own conclusion was that ongoing treatment is needed to keep the benefit, which is exactly the problem when the coverage is the thing that's gone.

If the money isn't there, stopping may still be the right call, and a forced stop goes better with a plan behind it. Ask your doctor whether to step down the dose gradually. It also helps to book a weigh-in for about three months out, so a regain doesn't sneak up on you, and to decide in advance what number would send you back to talk about other options.

Is weight-loss surgery an option if you can't afford the drug?

It can be, and the bar is lower than many people assume. The 2022 ASMBS and IFSO guidelines recommend metabolic and bariatric surgery for adults with a BMI of 35 or more whether or not they have weight-related conditions, and say it should be considered from a BMI of 30 for people with metabolic disease.

That's a big shift from the 1991 NIH criteria, which wanted a BMI of 35 plus at least one weight-related condition. Whether surgery suits you is a decision to make with your doctor and a surgeon. Plenty of people who were on a GLP-1 for weight would at least meet the criteria for that conversation.

The money works differently, too. The drug is a monthly bill that keeps going for as long as you want the result, so two years of Wegovy at the NovoCare price is $8,376 and three years is $12,564. Surgery is a one-time cost with lifelong follow-up attached. Our GLP-1 vs bariatric surgery comparison goes through the trade-offs side by side, and gastric sleeve cost by country shows what published prices look like at home and abroad. If you're weighing care abroad for the first time, start with our guide to bariatric surgery abroad.

Are there any add-ons once you're there?

If you do look at surgery abroad, read the quote line by line before anything else. The CDC's Yellow Book chapter on medical travel advises confirming what the base price includes, and notes that some facilities charge extra for follow-up. For a sleeve, ask specifically about these:

1. Pre-op bloodwork and any scans or endoscopy the surgeon wants before operating
2. Extra hotel nights if you need longer before you're cleared to fly
3. The vitamins and protein supplements you'll be on afterward
4. Follow-up visits, including remote check-ins once you're home

With JetWell, everything on your Care Plan is price-locked, and anything not on it is extra, so you can see what's in and what isn't before you pay. You pay a deposit to book, it goes toward your package price, and the balance is paid at the clinic when you arrive. Before paying a deposit anywhere, read what to ask before paying a deposit.

What happens if something feels wrong after you're home?

This is the part to settle before you book. The CDC advises arranging local follow-up before you travel and agreeing with both your US doctor and the treating surgeon how problems will be handled. It also says to bring home a full set of records, ideally in English. For weight-loss surgery, that means finding a US doctor or bariatric program willing to see you afterward, and knowing which number you'd call on day ten.

Eligible JetWell bookings can add JetCover by GPS, optional cover insured by Optimum Global Insurance Company Limited. It isn't included automatically, and JetWell isn't an insurer. Our week-by-week bariatric recovery guide covers what the first weeks home tend to look like.

A short checklist for the week your letter arrives

1. Read the notice for the end date, and whether prescriptions for type 2 diabetes are treated differently.
2. Ask your doctor about an appeal, and if you're on Medicare, whether you qualify for the GLP-1 Bridge.
3. Price the manufacturer self-pay options and check whether your HSA or FSA can cover them.
4. If you'll be stopping, plan the stop and a three-month weigh-in with your doctor.
5. Ask whether you meet the 2022 surgery criteria, and if you do, compare the cost over two or three years.

If surgery ends up on your list, you can ask Jett about weight-loss surgery and talk it through at your own pace.